Action | Date | Index | Provider |
---|---|---|---|
Join | 2024 | EGX33 Shariah Index | Egyptian Exchange |
Join | 2023 | EGX70 EWI Index | Egyptian Exchange |
Leave | 2023 | EGX 30 | Egyptian Exchange |
Leave | 2023 | EGX30 Capped | Egyptian Exchange |
Leave | 2023 | EGX30 TR | Egyptian Exchange |
Join | 2022 | EGX 50 EWI | Egyptian Exchange |
Join | 2021 | EGX 30 | Egyptian Exchange |
Join | 2021 | EGX30 Capped | Egyptian Exchange |
Join | 2021 | EGX30 TR | Egyptian Exchange |
Leave | 2021 | EGX70 EWI Index | Egyptian Exchange |
Leave | 2021 | EGX 50 EWI | Egyptian Exchange |
Join | 2020 | EGX 50 EWI | Egyptian Exchange |
Join | 2020 | EGX100 EWI | Egyptian Exchange |
Join | 2020 | EGX 100 | Egyptian Exchange |
Join | 2020 | EGX70 EWI Index | Egyptian Exchange |
Join | 2020 | Health Care & Pharmaceuticals | Egyptian Exchange |
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic |
Second Industrial Zone, plot number 5, Sixth of October, Egypt. |
T : +20 2 38202766 |
F : +20 2 38202910 |
www.remco.com.eg |
[email protected] |
Title | Name | As Of |
---|---|---|
Chairman: | Ayman Abbas | 2022 |
Deputy Chairman: | Shamel Abo Al Fadl | 2022 |
Managing Director: | Amr Mosaad | 2022 |
Board Member: | Hatem Soliman | 2019 |
Mirna Arif | 2023 | |
Mohamed Abdulmajeed | 2022 | |
Karim Zahran | 2022 | |
Mahmoud Fayek | 2022 | |
Tareq Abdul Rahman | 2022 | |
Mohammed Al Shora | 2022 |
Date | Title | File |
---|---|---|
2024 | Rameda Quarterly Financials Report Q3 2024 | |
2024 | Rameda Quarterly Financials Report Q3 2024 | |
2024 | Rameda Quarterly Financials Report Q2 2024 | |
2024 | Rameda Non- consolidated Quarterly Financials Report Q2 2024 | |
2024 | Rameda Non- consolidated Quarterly Financials Report Q1 2024 | |
2024 | Rameda Quarterly Financials Report Q1 2024 | |
2024 | Rameda Annual Financials Report 2023 | |
2024 | Rameda Non- consolidated Annual Financials Report 2023 | |
2023 | Rameda Quarterly Financials Report Q3 2023 | |
2023 | Rameda Non- consolidated Quarterly Financials Report Q3 2023 | |
2023 | Rameda Non- consolidated Quarterly Financials Report Q2 2023 |